{
  "docId": "019de516-9989-7672-a652-fe437099830c",
  "docSlug": "dc4b6dd31d750eecf6a392f7e2ae4db2",
  "documentTitle": "MaxCyte | Investor Presentation Deck | 22 slides",
  "authorId": "maxcyte",
  "authorName": "MaxCyte",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 22,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "traction",
  "function": "show_traction",
  "density": "overcrowded",
  "nDataPoints": 5,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-9989-7672-a652-fe437099830c/5",
  "deckHref": "/decks/019de516-9989-7672-a652-fe437099830c",
  "deckJsonHref": "/decks/019de516-9989-7672-a652-fe437099830c.json",
  "deckAnchorHref": "/decks/019de516-9989-7672-a652-fe437099830c#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.26,
        "w": 0.86,
        "x": 0.068,
        "y": 0.17
      },
      "kind": "diagram",
      "text": "75+ Potential SPL Partnerships Current addressable market**; 23 SPL Partnerships signed since 2017; 125+ Programs* Clinical Licenses that are part of our SPLs; 16 Programs are currently active in the clinic*",
      "attrs": {},
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f00854da-92ea-4587-8b8c-6d72b8a73a75",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.16,
        "w": 0.97,
        "x": 0.015,
        "y": 0.71
      },
      "kind": "image",
      "text": "Allogene, Invios, Beam, Caribou Biosciences, Vertex, Celularity, Sana Biotechnology, Nkarta Therapeutics, Curamys, Walking Fish Therapeutics, Lyell, CRISPR Therapeutics, Editas Medicine, Kite, KSQ, Myelcid, Precision Biosciences, VOR Biopharma, Intima Bioscience, LG Chem, CatamaranBio, Vittoria Biotherapeutics, Prime Medicine",
      "attrs": {},
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6f10a018-afd2-4f8c-8e3b-026ab26bb792",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.73,
        "x": 0.138,
        "y": 0.54
      },
      "kind": "metric",
      "text": "23 Strategic Platform Licenses (SPL) Partnerships, including 5 so far in 2023",
      "attrs": {},
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84a03c0a-94dc-4392-9e94-bb32d1e25827",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.17,
        "x": 0.658,
        "y": 0.52
      },
      "kind": "source-note",
      "text": "*Updated as of December 31, 2022",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07b72561-7b2d-42b4-a0cf-a059e3db9257",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.12,
        "x": 0.035,
        "y": 0.508
      },
      "kind": "source-note",
      "text": "**Number of gene-modified ex-vivo cell therapy companies using non-viral delivery.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb480a61-3b19-4551-8b78-5077482f2d13",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.17,
        "x": 0.801,
        "y": 0.97
      },
      "kind": "source-note",
      "text": "© 2023 MaxCyte, Inc. All Rights Reserved",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e99dafce-081a-49b8-9164-6554c778e27e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.65,
        "x": 0.042,
        "y": 0.08
      },
      "kind": "title",
      "text": "MaxCyte: Leading Partner for Complex Cellular Engineering",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1df32fed-d328-4f3e-89c1-b2282cedd99e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "2x2 matrix",
      "slug": "matrix-2x2",
      "agent": null,
      "layer": "slide",
      "matchId": "e5cd496c-902c-4aac-90f7-2733734fba77",
      "evidence": "The slide mentions a '75+ Potential SPL Partnerships' and '23 SPL Partnerships signed since 2017', which could be part of a 2x2 matrix.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "216488c0-4dde-4431-83a8-55579256c44d",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Traction is highlighted on page 5",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}